Cadence vs Dimer Health (2026)
Both put clinicians and software around a patient at home and they choose different moments to do it. Cadence runs continuous chronic care management for older adults, watching daily vitals for hypertension, diabetes, heart failure and lung disease, and it publishes the proportion of alerts its supervised agents close without a human, which is a rare and creditable disclosure. Dimer is clinician led transitional care, concentrated on the period immediately after discharge when readmission risk is highest and the patient is least supported. These are different budgets and different owners: chronic care management is an ongoing programme with a billing pathway, transitional care is an episode aimed at a penalty. The question is not which is better but which failure your organisation is currently paying for, and the answer is usually visible in your readmission numbers.
- It publishes an autonomous resolution rate for its agents rather than describing supervision, which makes the human in the loop claim checkable rather than rhetorical.
- It is delivered in partnership with health systems and billed through chronic care management, so it fits an existing reimbursement pathway rather than requiring a new budget line.
- Conditions and population are enumerated precisely, which lets a buyer match the programme against its own attributed panel rather than against a general claim.
- The clinical model is different in kind: clinician led transitional care aimed at the days after discharge, which is where avoidable readmission is decided.
- Transitional care is a bounded episode with a measurable endpoint, so the programme's effect is easier to attribute than an ongoing monitoring service.
- For an organisation whose penalty exposure is readmissions rather than chronic disease control, the intervention window matters more than the monitoring breadth.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Cadence and Dimer Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Cadence | Dimer Health |
|---|---|---|
| Primary category | Remote Monitoring & Chronic Care | Remote Monitoring & Chronic Care |
| Founded | Not recorded | 2023 |
| Headquarters | New York, New York | Florham Park, New Jersey |
| Website | cadence.care | dimerhealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Cadence its top capability grade on Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Dimer Health, Cadence grades higher on Clinical and Operational Evidence, FDA and Regulatory Status and Commercial Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Dimer Health its top capability grade on Autonomy and Oversight Model and Setting and Specialty Coverage. Set against Cadence, Dimer Health grades higher on EHR and Interoperability Depth and Setting and Specialty Coverage. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Cadence or Dimer Health?
On the axes where the AI Health Index separates them, Cadence grades higher on Clinical and Operational Evidence, FDA and Regulatory Status and Commercial Transparency, and Dimer Health grades higher on EHR and Interoperability Depth and Setting and Specialty Coverage. Cadence leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Cadence and Dimer Health differ most?
The widest separation the AI Health Index records between Cadence and Dimer Health is on Clinical and Operational Evidence, where Cadence grades A and Dimer Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Cadence and Dimer Health grade the same?
The AI Health Index grades Cadence and Dimer Health the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Cadence and Dimer Health not disclosed?
At the last review, at least one of Cadence and Dimer Health published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
Both vendors sell a clinical service with software attached, so the comparison is partly a staffing decision and the pricing should be read against the cost of running the equivalent programme internally. Cadence publishes no security attestation, trust centre, retention position or training use statement, and its record system integration is claimed without documentation. Neither vendor publishes subgroup performance.
In remote monitoring, adherence and connectivity vary with income, age and housing stability, and a patient whose device stops reporting is indistinguishable from a patient who is doing well, which is the failure mode both programmes should be asked how they detect.